Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2024 12:09 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics Announces the Publication of Groundbreaking GCC19CART™ Study to Treat mCRC in JAMA Oncology

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
October 31, 2023 10:38 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Presented Updated Data of the China-IRB Study of GCC19CART in Metastatic Colorectal Cancer at European Society for Medical Oncology (ESMO) Congress 2023

ROCKVILLE, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
May 24, 2023 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Presented Data at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting

ROCKVILLE, Md., May 24, 2023 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
May 02, 2023 10:12 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Presented Updated Data at the American Association for Cancer Research (AACR) Annual Meeting

ROCKVILLE, Md., May 02, 2023 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
August 18, 2022 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Announces First Patient Enrolled for the Company’s Phase I Trial of GCC19CART for Relapsed/Refractory Metastatic Colorectal Cancer

ROCKVILLE, Md., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
May 26, 2022 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Announces Presentation at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

ROCKVILLE, Md., May 26, 2022 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
May 17, 2022 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting

ROCKVILLE, Md., May 17, 2022 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
April 21, 2022 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting

Clinical Data from one research site for GCC19CART, ICT’s lead solid tumor program, for 3rd line plus relapsed/refractory metastatic colorectal cancer (R/R mCRC) shows patients receiving a dose of...
April 19, 2022 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Receives FDA Fast Track Designation for GCC19CART, its Lead Solid Tumor Candidate, in the Treatment of Patients with Relapsed or Refractory Metastatic Colorectal Cancer

GCC19CART is an autologous CAR T therapy candidate that has shown promising results in over 30 R/R mCRC patients in ChinaICT plans to initiate a Phase 1 Trial of GCC19CART in the U.S. for the...
April 06, 2022 20:00 ET | Source: Innovative Cellular Therapeutics

斯丹赛生物技术公司任命Robert Dallimore 作为质量与合规高级副总裁

ROCKVILLE, Md., April 07, 2022 (GLOBE NEWSWIRE) -- 致力于开发以实体瘤为重点的嵌合抗原受体（CAR）T细胞治疗综合平台的临床阶段生物技术公司--斯丹赛生物技术（即：Innovative Cellular Therapeutics，简称“ICT”）今天宣布，任命 Robert Dallimore 为质量与合规高级副总裁。 ...